Source: OTC Breaking News

ISR: Medpace and DCRI-Duke Exceed Expectations in Phase II/III Staff Characteristics

Informing Pharmaceutical Drug Developers and Service Providers CARY, NC / ACCESSWIRE / April 26, 2017 / Industry Standard Research (ISR) has released a new report, CRO Quality Benchmarking - Phase II/III Service Providers (9th Edition), containing findings focused on service provider selection and evaluation. Kevin Olson, CEO, explains, "This report offers critical information for those [...]

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Kevin Olson's photo - CEO of Industry Standard Research

CEO

Kevin Olson

CEO Approval Rating

70/100

Read more